{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T15:21:14Z","timestamp":1770218474528,"version":"3.49.0"},"reference-count":72,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[1987,10,1]],"date-time":"1987-10-01T00:00:00Z","timestamp":560044800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1987,10,1]]},"abstract":"<jats:title>Abstarct<\/jats:title>\n                  <jats:p>Equine antiserum to core lipopolysaccharide (LPS) was evaluated in a double-blind prospective study for therapeutic benefit in suspected septicemia in neonatal foals. Forty foals younger than 7 days of age were included in the study by satisfaction of clinical and laboratory criteria, suggestive of gram-negative septicemia. Twenty-two foals were treated with core LPS antiserum (plasma produced from horses which were hyperimmunized with rough gram-negative mutant bacterin) and 18 foals received \u201cnonimmune\u201d plasma (from horses prior to immunization against core LPS). All foals received antimicrobials, fluids, and other supportive care measures, depending on clinical signs and according to accepted current practice. The clinical and laboratory data of each foal were monitored and recorded daily for 14 days after plasma treatment or until death.<\/jats:p>\n                  <jats:p>The overall survival rate of these 40 foals with septicemia was 52.5%. The most prevalent diagnoses in addition to septicemia were enteritis and pneumonia. Of 30 positive bacterial cultures, 93% were due to gram-negative organisms. There was no statistically significant increase in survival rate in the 22 foals given core LPS antiserum (P\u00b1 0.05).<\/jats:p>","DOI":"10.1111\/j.1939-1676.1987.tb02012.x","type":"journal-article","created":{"date-parts":[[2010,3,10]],"date-time":"2010-03-10T08:28:08Z","timestamp":1268209688000},"page":"175-182","source":"Crossref","is-referenced-by-count":36,"title":["Therapy of Suspected Septicemia in Neonatal Foals Using Plasma-containing Antibodies to Core Lipopolysaccharide (LPS)"],"prefix":"10.1093","volume":"1","author":[{"given":"Debra Deem","family":"Morris","sequence":"first","affiliation":[{"name":"New Bolton Center, University of Pennsylvania School of Veterinary Medicine Department of Clinical Studies, , Kennett Square, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert H.","family":"Whitlock","sequence":"additional","affiliation":[{"name":"New Bolton Center, University of Pennsylvania School of Veterinary Medicine Department of Clinical Studies, , Kennett Square, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1987,10,1]]},"reference":[{"issue":"6","key":"2026020303221187600_b1","first-page":"341","article-title":"Bacterial infections of the newborn foal. Part I. Clincial presentation, laboratory findings and pathogenesis","volume":"6","author":"Morris","year":"1984","journal-title":"Com-pend Contin Educ Pract Vet"},{"issue":"4","key":"2026020303221187600_b2","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.2042-3306.1984.tb01950.x","article-title":"Clinical and clinicopathological characteristics of the septicemic neonatal foal: Review of 38 cases","volume":"16","author":"Koterba","year":"1984","journal-title":"Equine Vet J"},{"key":"2026020303221187600_b3","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.2460\/javma.1986.189.11.1454","article-title":"Follow-up evaluation of horses after neonatal intensive care","volume":"189","author":"Baker","year":"1986","journal-title":"J Am Vet Med Assoc"},{"key":"2026020303221187600_b4","first-page":"S256","article-title":"Septicemia in the neonatal foal","volume":"8","author":"Carter","year":"1986","journal-title":"Compend Contin Educ Pract Vet"},{"key":"2026020303221187600_b5","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1001\/archinte.1962.03620240029006","article-title":"Gram-negative bacteremia. 1. Etiology and ecology","volume":"110","author":"McCabe","year":"1962","journal-title":"Arch Intern Med"},{"key":"2026020303221187600_b6","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1093\/clinids\/6.4.428","article-title":"Lipopolysaccharides: structural principles and biologic activities","volume":"6","author":"Luderitz","year":"1984","journal-title":"Rev Infect Dis"},{"key":"2026020303221187600_b7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1751-0813.1985.tb07288.x","article-title":"Pathogenesis of bacterial infections: some determinants of virulence in Gram-negative bacteria","volume":"62","author":"Woolcock","year":"1985","journal-title":"Aust Vet J"},{"key":"2026020303221187600_b8","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1001\/archinte.1985.00360070082014","article-title":"Improved mortality in gram-negative bacillary bacteremia","volume":"145","author":"McCue","year":"1985","journal-title":"Arch Intern Med"},{"key":"2026020303221187600_b9","first-page":"55","article-title":"Glucocorticoid and antibiotic effects of hepatic microcirculation and associated host responses in lethal gram-negative bacteremia","volume":"40","author":"Balis","year":"1979","journal-title":"Lab Invest"},{"key":"2026020303221187600_b10","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/infdis\/151.6.1012","article-title":"Role of antibiotic class in the rate of liberation of endotoxin during therapy for experimental gram-negative bacterial sepsis","volume":"151","author":"Shenep","year":"1985","journal-title":"J Infect Dis"},{"key":"2026020303221187600_b11","first-page":"103","volume-title":"Immunopharmacology and the Regulations of Leukocyte Function","author":"Reitschel","year":"1982"},{"key":"2026020303221187600_b12","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1093\/infdis\/151.6.995","article-title":"Cross-reactive immunoprotective antibodies to Escherichia coli Ol 11 rough mutant J5","volume":"151","author":"Sakulramrung","year":"1985","journal-title":"J Infect Dis"},{"key":"2026020303221187600_b13","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/archsurg.1986.01400010064008","article-title":"Immunotherapy of gram-negative bacterial sepsis. A single murine monoclonal antibody provides cross-genera protection","volume":"121","author":"Dunn","year":"1986","journal-title":"Arch Surg"},{"key":"2026020303221187600_b14","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1128\/iai.42.1.250-256.1983","article-title":"Common lipopolysaccharide specificity: new type of antigen residing in the inner core region of S- and R-form lipopolysaccharides from different families of gram-negative bacteria","volume":"42","author":"Brade","year":"1983","journal-title":"Infec Immun"},{"key":"2026020303221187600_b15","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1093\/infdis\/136.Supplement.S161","article-title":"Cross-reactive antigens: their potential for immunization-induced immunity to gram-negative bacteria","volume":"136","author":"McCabe","year":"1977","journal-title":"J Infect Dis"},{"key":"2026020303221187600_b16","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1128\/iai.45.3.631-636.1984","article-title":"Monoclonal anti bodies specific for Escherichia coli J-5 lipopolysaccharide: cross-reaction with other gram-negative bacterial species","volume":"45","author":"Mutharia","year":"1984","journal-title":"Infect Immun"},{"key":"2026020303221187600_b17","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1128\/iai.46.3.677-681.1984","article-title":"Mouse monoclonal antibodies reactive with J5 lipopolysaccharide exhibit extensive serologic cross-reactivity with a variety of gram-negative bacteria","volume":"46","author":"Nelles","year":"1984","journal-title":"Infect Immun"},{"key":"2026020303221187600_b18","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/infdis\/151.6.988","article-title":"Age-related prevalence of human serum IgG and IgM antibody to the core glycolipid of Escherichia coli strain J5, as measured by ELISA","volume":"151","author":"Law","year":"1985","journal-title":"J Infect Dis"},{"key":"2026020303221187600_b19","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/infdis\/152.5.954","article-title":"Cross-reactivity of rabbit anti- bodies to lipopolysaccharides of Escherichia coli J-5 and other gram-negative bacteria","volume":"152","author":"Siber","year":"1985","journal-title":"J Infect Dis"},{"key":"2026020303221187600_b20","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/BF02013970","article-title":"Cross-re- activity of monoclonal antibodies against lipopolysaccharides of gram-negative bacteria","volume":"5","author":"Jongh-Leuvenink","year":"1986","journal-title":"Eur J Clin Microbiol"},{"key":"2026020303221187600_b21","doi-asserted-by":"crossref","first-page":"433","DOI":"10.4049\/jimmunol.111.2.433","article-title":"Treatment of coli and Klebsiella bacteremia in agranulocytic animals with antiserum to a UDP-GAL epimerase-deficient mutant","volume":"111","author":"Ziegler","year":"1973","journal-title":"J Immunol"},{"key":"2026020303221187600_b22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/infdis\/147.1.57","article-title":"Immunization with rough mutants of Salmonella minnesota. IV. Protection by antisera to O and rough antigens against endotoxin","volume":"147","author":"Johns","year":"1983","journal-title":"J Infect Dis"},{"key":"2026020303221187600_b23","first-page":"440","article-title":"Anticore endotoxin F (ab)2 equine immunoglobulin fragments protect against lethal effects of gram-negative bacterial sepsis","volume":"96","author":"Dunn","year":"1984","journal-title":"Surgery"},{"key":"2026020303221187600_b24","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/0022-4804(85)90041-1","article-title":"Metabolic effects of pretreatment with Escherichia coli J5 antiserum on guinea pig gram-negative bacterial sepsis","volume":"38","author":"Dunn","year":"1985","journal-title":"J Surg Res"},{"key":"2026020303221187600_b25","first-page":"283","article-title":"Efficacy of type-specific and cross-reactive murine monoclonal antibodies directed against endotoxin during experimental sepsis","volume":"98","author":"Dunn","year":"1985","journal-title":"Surgery"},{"key":"2026020303221187600_b26","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1056\/NEJM198211113072001","article-title":"Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli.","volume":"307","author":"Ziegler","year":"1982","journal-title":"N Engl J Med"},{"key":"2026020303221187600_b27","first-page":"158","article-title":"The use of anti-LPS antibodies in the management of septic shock: a preliminary report","volume":"65","author":"Gaffin","year":"1984","journal-title":"South Afr Med J"},{"key":"2026020303221187600_b28","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0140-6736(84)92324-9","article-title":"Anti-lipopolysaccharide (anti- LPS) immunotherapy in the management of septic shock of obstetrical and gynecological origin","volume":"i","author":"Lachman","year":"1984","journal-title":"Lancet"},{"key":"2026020303221187600_b29","first-page":"525","article-title":"Active and passive immunization for blockade of endotoxemia","author":"Garner","year":"1985"},{"key":"2026020303221187600_b30","doi-asserted-by":"crossref","first-page":"544","DOI":"10.2460\/ajvr.1986.47.03.544","article-title":"Endotoxemia in horses: Protection provided by antiserum to core lipopolysaccharide","volume":"47","author":"Morris","year":"1986","journal-title":"Am J Vet Res"},{"key":"2026020303221187600_b31","first-page":"1439","article-title":"Prophylactic Antibody to Core Lipopolysaccharide in Neutropenia","author":"Wolf","year":"1980"},{"key":"2026020303221187600_b32","first-page":"335","article-title":"Prophylaxis and therapy with anti-endotoxin hyperimmune serum against gastroenteritis and endotoxemia in horses","author":"Gaffin","year":"1982"},{"key":"2026020303221187600_b33","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/0002-9343(80)90101-1","article-title":"Gram-Negative Bacteremia. III. Reassessment of Etiology, Epidemiology and Ecology in 612 Patients","volume":"68","author":"Kreger","year":"1980","journal-title":"Am J Med"},{"key":"2026020303221187600_b34","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/clinids\/5.4.629","article-title":"Analysis of 1186 Episodes of Gram-Negative Bacteremia in Non-University Hospitals: The Effects of Antimicrobial therapy","volume":"5","author":"Bryan","year":"1983","journal-title":"Rev Infect Dis"},{"key":"2026020303221187600_b35","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/00003246-198606000-00001","article-title":"Complement activation in septic shock patients","volume":"14","author":"Sprung","year":"1986","journal-title":"Crit Care Med"},{"key":"2026020303221187600_b36","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJM197512112932416","article-title":"Complement activation in septic shock","volume":"293","author":"Robin","year":"1975","journal-title":"N Engl J Med"},{"key":"2026020303221187600_b37","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/00003246-198205000-00004","article-title":"Complement activation in septic shock due to gram-negative and gram-positive bacteria","volume":"10","author":"Leon","year":"1982","journal-title":"Crit Care Med"},{"key":"2026020303221187600_b38","doi-asserted-by":"crossref","first-page":"S167","DOI":"10.1093\/infdis\/136.Supplement.S167","article-title":"Antibody to cell wall glycolipid of gram-negative bacteria induction of immunity to bacteremia and endotoxemia","volume":"136","author":"Braude","year":"1977","journal-title":"J Infect Dis"},{"key":"2026020303221187600_b39","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1084\/jem.147.4.1007","article-title":"Neutralization of meningococcal endotoxin by antibody to core glycolipid","volume":"147","author":"Davis","year":"1978","journal-title":"J Exp Med"},{"key":"2026020303221187600_b40","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1172\/JCI110512","article-title":"Induction of immunity against Haemophilus influenzae type B infection by Escherichia coli core lipopolysaccharide","volume":"69","author":"Marks","year":"1982","journal-title":"J Clin Invest"},{"key":"2026020303221187600_b41","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/infdis\/151.6.1005","article-title":"Failure of monoclonal antibodies to core glycolipid to bind intact smooth strains of Escherichia coli.","volume":"151","author":"Gigliotti","year":"1985","journal-title":"J Infect Dis"},{"key":"2026020303221187600_b42","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/BF01642875","article-title":"Antiserum Against Escherichia coli J5: A Re-evalution of its In vitro and In vivo Activity Against Heterologous Gram-Negative Bacteria","volume":"13","author":"Trautmann","year":"1985","journal-title":"Infection"},{"key":"2026020303221187600_b43","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1099\/00221287-94-1-107","article-title":"Relationship of structure to function in bacterial endotoxins: Serologically cross-reactive components and their effect on protection of mice against some gram-negative infections","volume":"94","author":"Ng","year":"1976","journal-title":"J Gen Microbiol"},{"key":"2026020303221187600_b44","doi-asserted-by":"crossref","first-page":"292","DOI":"10.4049\/jimmunol.100.2.292","article-title":"A proposed mechanism for natural immunity of enterobacterial pathogens","volume":"100","author":"Chedid","year":"1968","journal-title":"J Immunol"},{"key":"2026020303221187600_b45","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3181\/00379727-158-40231","article-title":"Experimental gram- negative bacterial sepsis: Re-evaluation of the ability of rough mutant antisera to protect mice","volume":"158","author":"Greisman","year":"1978","journal-title":"Proc Soc Exp Biol Med"},{"key":"2026020303221187600_b46","first-page":"276","article-title":"Properties of Human Anti-Li- popolysaccharide Gamma Globulin: Specificity and Protective Effects","volume":"48","author":"Gaffin","year":"1985","journal-title":"Vox Surg"},{"key":"2026020303221187600_b47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1128\/iai.17.1.9-15.1977","article-title":"Immunization with R mutants of Salmonella minnesota II. Serological response to lipid A and the lipopolysaccharide of Re mutants","volume":"17","author":"Johns","year":"1977","journal-title":"Infect Immunol"},{"key":"2026020303221187600_b48","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1084\/jem.153.2.324","article-title":"Subclass-restricted IgG polyclonal antibody production in mice injected with lipid A-rich lipo-polysaccharides","volume":"153","author":"Izui","year":"1981","journal-title":"J Exp Med"},{"key":"2026020303221187600_b49","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/infdis\/144.6.599","article-title":"Type-specific vs. cross-protective vaccination for gram-negative bacterial pneumonia","volume":"144","author":"Pennington","year":"1981","journal-title":"J Infect Dis"},{"issue":"12","key":"2026020303221187600_b50","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.2460\/ajvr.1986.47.12.2554","article-title":"Endotoxemia in neonatal calves given antiserum to a mutant Escherichia coli (J-5)","volume":"47","author":"Morris","year":"1986","journal-title":"Am J Vet Res"},{"key":"2026020303221187600_b51","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/BF01642870","article-title":"Preliminary study on administration of high-titer Lipid A antibody serum in sepsis and septic shock patients","volume":"13","author":"Marget","year":"1985","journal-title":"Infection"},{"key":"2026020303221187600_b52","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.4049\/jimmunol.132.5.2590","article-title":"An immunoprotective monoclonal antibody to LPS","volume":"132","author":"Kirkland","year":"1984","journal-title":"J Immunol"},{"key":"2026020303221187600_b53","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1073\/pnas.82.6.1790","article-title":"Protection against gram-negative bacteremia and endotoxemia with human monoclonal IgM antibodies","volume":"82","author":"Teng","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026020303221187600_b54","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1128\/iai.17.1.16-20.1977","article-title":"Immunization with R mutants of Salmonella minnesota. III. Comparison of protective effect of immunization with lipid A and the Re mutant","volume":"17","author":"Bruins","year":"1977","journal-title":"Infect Immun"},{"key":"2026020303221187600_b55","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1128\/iai.48.3.776-781.1985","article-title":"Characterization of two different antibody specificities recognizing distinct antigenic determinants in free lipid A of Escherichia coli.","volume":"48","author":"Brade","year":"1985","journal-title":"Infect Immun"},{"key":"2026020303221187600_b56","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/infdis\/128.Supplement_1.S157","article-title":"Treatment and prevention of intravascular coagulation with antiserum to endotoxin","volume":"128","author":"Braude","year":"1973","journal-title":"J Infect Dis"},{"key":"2026020303221187600_b57","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2460\/javma.1982.181.10.983","article-title":"Mechanisms of action by immunologic adjuvants","volume":"181","author":"Osebold","year":"1982","journal-title":"J Am Vet Med Assoc"},{"issue":"2","key":"2026020303221187600_b58","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1128\/iai.53.2.298-304.1986","article-title":"Mechanisms involved in protection provided by immunization against core lipopoly-saccharides of E. coli J-5 from lethal Haemophilus pleuro-pneumoniae","volume":"53","author":"Fenwick","year":"1986","journal-title":"Infect Immun"},{"key":"2026020303221187600_b59","first-page":"48","article-title":"Protection from endotoxic shock in calves by antibodies against common LPS core antigens induced by immunization with E. coli (J5). Abstract","author":"Culior","year":"1984"},{"key":"2026020303221187600_b60","first-page":"352","article-title":"Decreased mortality and severity of infection from salmonellosis in calves immunized with E. coli (strain J5). Abstract","author":"Culior","year":"1985"},{"key":"2026020303221187600_b61","first-page":"1223","article-title":"Mechanisms of endotoxin tolerance. V. Specificity of the early and late phases of pyrogenic tolerance","volume":"103","author":"Griesman","year":"1969","journal-title":"J Immunol"},{"key":"2026020303221187600_b62","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/infdis\/154.5.784","article-title":"Neutralization and lipoprotein binding of lipopolysaccharides in tolerant rabbit serum","volume":"154","author":"Warren","year":"1986","journal-title":"J of Infect Dis"},{"key":"2026020303221187600_b63","first-page":"229","volume-title":"Bacterial Endotoxins and Host Response","author":"Peavy","year":"1980"},{"key":"2026020303221187600_b64","first-page":"165","article-title":"The response of isolated rabbit macrophages to lipopolysaccharide (LPS)","volume":"8","author":"Maier","year":"1981","journal-title":"Circ Shock"},{"key":"2026020303221187600_b65","first-page":"605","article-title":"Modulation of macrophage Arachidonic Acid Metabolism: Potential Role in the Susceptibility of Rats to Endotoxic Shock","volume":"9","author":"Cook","year":"1982","journal-title":"Circ Shock"},{"key":"2026020303221187600_b66","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1128\/iai.45.1.278-280.1984","article-title":"Species Differences in Kupffer Cells and Endotoxin Sensitivity","volume":"45","author":"McCuskey","year":"1984","journal-title":"Infect Immun"},{"key":"2026020303221187600_b67","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0344-0338(85)80193-X","article-title":"Distribution and Localization of Endotoxin in the Reticuloendothelial System (RES) and in the Main Vessels of the Rat during Shock","volume":"179","author":"Freudenberg","year":"1985","journal-title":"Pathol Res Pract"},{"key":"2026020303221187600_b68","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev.iy.02.040184.001435","article-title":"The cell biology of macrophage activation","volume":"2","author":"Adams","year":"1984","journal-title":"Ann Rev Immunol"},{"key":"2026020303221187600_b69","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/0022-4804(84)90112-4","article-title":"Microthrombosis during endotoxemia: Potential Role of Hepatic versus alveolar macrophages","volume":"36","author":"Maier","year":"1984","journal-title":"J Surg Res"},{"key":"2026020303221187600_b70","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0165-2478(85)90047-1","article-title":"The role of serum in Interleukin 1 Production by Human Monocytes Activated by endotoxins and their Polysaccharide Moieties","volume":"10","author":"Cavaillon","year":"1985","journal-title":"Immunol Lett"},{"key":"2026020303221187600_b71","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0006-291X(85)80014-0","article-title":"Platelet Activating Factor (PAF). Involvement in Endotoxin-Induced Hypotension in Rats. Studies with PAF-receptor antagonist kadswrenone","volume":"127","author":"Doebber","year":"1985","journal-title":"Biochem Biophys Res Commun"},{"key":"2026020303221187600_b72","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1126\/science.3754653","article-title":"Control of cachectin (tumor necrosis factor) synthesis: Mechanism of endotoxin resistance","volume":"232","author":"Beutler","year":"1986","journal-title":"Science"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1939-1676.1987.tb02012.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/1\/4\/175\/66680407\/j.1939-1676.1987.tb02012.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/1\/4\/175\/66680407\/j.1939-1676.1987.tb02012.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T08:22:34Z","timestamp":1770106954000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/1\/4\/175\/8450794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987,10,1]]},"references-count":72,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1987,10,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1939-1676.1987.tb02012.x","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1987,10]]},"published":{"date-parts":[[1987,10,1]]}}}